During the past decade, Instituto Nacional de Cardiologia Ignacio Chavez conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 20 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 14 clinical trials were completed. i.e. 60.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Nacional de Cardiologia Ignacio Chavez" #1 sponsor was "Instituto Nacional de Cardiologia Ignacio Chavez" with 21 trials, followed by "Actelion" with 11 trials sponsored, "Boehringer Ingelheim" with 7 trials sponsored, "United Therapeutics" with 5 trials sponsored and "Coordinación de Investigación en Salud, Mexico" with 5 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Nacional de Cardiologia Ignacio Chavez" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Instituto Nacional de Cardiologia Ignacio Chavez" with 2 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Nacional de Cardiologia Ignacio Chavez" are "Pulmonary Arterial Hypertension" (13 trials), "Coronary Artery Disease" (6 trials), "Heart Failure" (6 trials), "Chronic Thromboembolic Pulmonary Hypertension" (4 trials) and "Pulmonary Hypertension" (4 trials). Many other conditions were trialed in "Instituto Nacional de Cardiologia Ignacio Chavez" in a lesser frequency.

Most popular intervention types in "Instituto Nacional de Cardiologia Ignacio Chavez" are "Drug" (47 trials), "Other" (8 trials), "Device" (6 trials), "Procedure" (4 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Macitentan" (4 trials), "Curcumin" (2 trials), "Furosemide" (2 trials) and "Macitentan 10 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Nacional de Cardiologia Ignacio Chavez" are 67 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Nacional de Cardiologia Ignacio Chavez". undefined are not yet recruiting, 14 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Instituto Nacional de Cardiologia Ignacio Chavez, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Nacional de Cardiologia Ignacio Chavez, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 12 trials that are defined as “Not Applicable".